{"slideshow_credits": null, "snippet": "An advocacy group wants to manufacture psychedelic drugs to prove they are safe and beneficial, part of a global movement to revise drug policies.", "abstract": "Norwegian researcher Pal-Orjan Johansen is pushing for legalization of psychedelic drug LSD, as well as MDMA and psilocybin, substances banned in many countries around world; EmmaSofia, advocacy group Johansen formed with his wife Teri Krebs, has gained surprising amount of support in drug-averse nation, demonstrating momentum of growing effort to revise drug policies of 1970s.", "section_name": "World", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "HIGGINS", "rank": 1, "organization": ""}], "original": "By ANDREW HIGGINS", "contributor": "Henrik Pryser Libell contributed reporting."}, "web_url": "http://www.nytimes.com/2015/05/05/world/europe/an-uphill-campaign-in-norway-to-promote-lsd-as-a-human-right.html", "lead_paragraph": "An advocacy group wants to manufacture psychedelic drugs to prove they are safe and beneficial, part of a global movement to revise drug policies.", "headline": {"main": "Odd Push in Drug-Averse Norway: LSD Is O.K.", "print_headline": "Odd Push in Drug-Averse Norway: LSD Is O.K. "}, "_id": "5547352e38f0d80915694375", "word_count": "1296", "multimedia": [{"height": 126, "url": "images/2015/05/05/world/05norway-web2/05norway-web2-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/05/05/world/05norway-web2/05norway-web2-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2015/05/05/world/05norway-web2/05norway-web2-articleLarge.jpg", "legacy": {"xlarge": "images/2015/05/05/world/05norway-web2/05norway-web2-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/05/05/world/05norway-web2/05norway-web2-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/05/05/world/05norway-web2/05norway-web2-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-05-05T00:00:00Z", "source": "The New York Times", "news_desk": "Foreign", "keywords": [{"name": "subject", "value": "LSD (Lysergic Acid Diethylamide)", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Ecstasy (Drug)", "is_major": "Y", "rank": "2"}, {"name": "glocations", "value": "Norway", "is_major": "Y", "rank": "3"}, {"name": "persons", "value": "Johansen, Pal-Orjan", "is_major": "Y", "rank": "4"}, {"name": "organizations", "value": "EmmaSofia", "is_major": "Y", "rank": "5"}, {"name": "subject", "value": "Drug Abuse and Traffic", "is_major": "N", "rank": "6"}], "blog": [], "subsection_name": "Europe", "type_of_material": "News"}